4uq3
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
==Crystal structure of HLA-A0201 in complex with an azobenzene- containing peptide== | ==Crystal structure of HLA-A0201 in complex with an azobenzene- containing peptide== | ||
- | <StructureSection load='4uq3' size='340' side='right' caption='[[4uq3]], [[Resolution|resolution]] 2.10Å' scene=''> | + | <StructureSection load='4uq3' size='340' side='right'caption='[[4uq3]], [[Resolution|resolution]] 2.10Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[4uq3]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4UQ3 OCA]. For a <b>guided tour on the structure components</b> use [http:// | + | <table><tr><td colspan='2'>[[4uq3]] is a 6 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4UQ3 OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=4UQ3 FirstGlance]. <br> |
- | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=IPA:ISOPROPYL+ALCOHOL'>IPA</scene></td></tr> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=IPA:ISOPROPYL+ALCOHOL'>IPA</scene></td></tr> |
<tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=XFW:(2S)-2,5,5-TRIS(AZANYL)PENTANOIC+ACID'>XFW</scene>, <scene name='pdbligand=XY1:4-[(E)-[5-(2-AZANYLETHYL)-2-OXIDANYL-PHENYL]DIAZENYL]BENZOIC+ACID'>XY1</scene></td></tr> | <tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=XFW:(2S)-2,5,5-TRIS(AZANYL)PENTANOIC+ACID'>XFW</scene>, <scene name='pdbligand=XY1:4-[(E)-[5-(2-AZANYLETHYL)-2-OXIDANYL-PHENYL]DIAZENYL]BENZOIC+ACID'>XY1</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4uq2|4uq2]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4uq2|4uq2]]</td></tr> | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http:// | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=4uq3 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4uq3 OCA], [http://pdbe.org/4uq3 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4uq3 RCSB], [http://www.ebi.ac.uk/pdbsum/4uq3 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4uq3 ProSAT]</span></td></tr> |
</table> | </table> | ||
== Disease == | == Disease == | ||
Line 24: | Line 24: | ||
==See Also== | ==See Also== | ||
- | *[[Beta-2 microglobulin|Beta-2 microglobulin]] | + | *[[Beta-2 microglobulin 3D structures|Beta-2 microglobulin 3D structures]] |
== References == | == References == | ||
<references/> | <references/> | ||
Line 30: | Line 30: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Human]] | [[Category: Human]] | ||
+ | [[Category: Large Structures]] | ||
[[Category: Grotenbreg, G M]] | [[Category: Grotenbreg, G M]] | ||
[[Category: Lescar, J]] | [[Category: Lescar, J]] |
Revision as of 09:05, 21 October 2020
Crystal structure of HLA-A0201 in complex with an azobenzene- containing peptide
|
Categories: Human | Large Structures | Grotenbreg, G M | Lescar, J | Lim, P Y | Meijers, R | Thong, S Y | Verhelst, S H | Yap, J W | Azobenzene | Hla-a | Immune system | Synthetic peptide